Achillion Pharmaceuticals (ACHN) in Focus: Stock Rises 47.6% - Tale of the Tape - ANI Pharmaceuticals (NASDAQ:ANIP)

Achillion Pharmaceuticals, Inc. ACHN was a big mover last session, as its shares rose nearly 48% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent near-flat trend for the company, as the stock is now trading above the volatile price range of $2.67 to $2.95 in the past one-month timeframe.

In the last 30 days, the company witnessed one negative estimate revision while the Zacks Consensus Estimate remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Achillion Pharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Gilead Sciences Inc. GILD, ANI Pharmaceuticals, Inc. ANIP and Illumina Inc. ILMN. All three sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ACHILLION PHARM ACHN: Free Stock Analysis Report

ILLUMINA INC ILMN: Free Stock Analysis Report

GILEAD SCIENCES GILD: Free Stock Analysis Report

ANI PHARMACEUT ANIP: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Market News and Data brought to you by Benzinga APIs

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Achillion Pharmaceuticals (ACHN) in Focus: Stock Rises 47.6% - Tale of the Tape

Comments